| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79f0a9cf228ec5df422294a38aa0c896 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-282 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2008-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ef62b5ab0997f0f78c2d04c4c6671dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a64f00592b8af68d858a54dc89ad0d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e85f7fc01428662b22d6ed9431dfd32a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1f2ef6319d3a22823999794c1d27e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a5750e611cab0812fc18d7309984e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be27cc2abbde77dd80ecba8dec714fa9 |
| publicationDate |
2010-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2192892-A2 |
| titleOfInvention |
Pulsatile gastric retentive dosage forms |
| abstract |
Dosage forms for delayed and pulsed release of therapeutic agents into the stomach are described. The dosage forms are gastric retentive dosage forms that achieve release of the therapeutic agent into the stomach and upper gastrointestinal tract subsequent to administration of the dosage form. The dosage forms find particular use in administration of acid-labile active agents such as proton pump inhibitors, and in treating gastric acid secretion such as gastroesophageal reflux disease (GERD) and nocturnal acid breakthrough (NAB). |
| priorityDate |
2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |